In addition, GRK2 inhibition may have therapeutic effects in a variety of renal diseases, such as SLE‐related kidney injury, DN, age‐related kidney injury, hypertension‐related kidney injury, and CRS. This evidence concerns the gene GRK2 and liver dysplastic nodule.